Qube Research & Technologies Ltd reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 57.4% in the second quarter, HoldingsChannel reports. The fund owned 1,430 shares of the medical equipment provider’s stock after selling 1,928 shares during the period. Qube Research & Technologies Ltd’s holdings in Intuitive Surgical were worth $750,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also modified their holdings of the company. Manchester Financial Inc. purchased a new position in Intuitive Surgical in the second quarter worth about $25,000. Icon Wealth Partners LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $26,000. Advisory Alpha LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $32,000. Ellis Investment Partners LLC purchased a new position in shares of Intuitive Surgical during the first quarter valued at approximately $34,000. Finally, FTB Advisors Inc. raised its holdings in shares of Intuitive Surgical by 333.3% during the first quarter. FTB Advisors Inc. now owns 78 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 60 shares during the last quarter. 86.12% of the stock is owned by institutional investors.
ISRG has been the subject of several research reports. Raymond James decreased their price objective on shares of Intuitive Surgical from $630.00 to $610.00 and set an “outperform” rating for the company in a report on Monday, April 22nd. Northland Securities set a $375.00 price objective on shares of Intuitive Surgical and gave the company a “sell” rating in a report on Friday, July 19th. Zacks Investment Research cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, April 24th. BTIG Research reissued a “hold” rating on shares of Intuitive Surgical in a report on Sunday, April 21st. Finally, Piper Jaffray Companies boosted their price objective on shares of Intuitive Surgical from $610.00 to $633.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Three analysts have rated the stock with a sell rating, three have given a hold rating and ten have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $579.92.
NASDAQ ISRG traded up $0.44 during trading hours on Monday, hitting $495.89. 14,275 shares of the company’s stock traded hands, compared to its average volume of 599,549. The business’s fifty day moving average price is $523.78 and its two-hundred day moving average price is $526.31. The firm has a market capitalization of $57.61 billion, a P/E ratio of 51.98, a P/E/G ratio of 3.71 and a beta of 1.12. Intuitive Surgical, Inc. has a 52 week low of $430.24 and a 52 week high of $589.32.
Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $1.02. The company had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.03 billion. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period in the previous year, the business posted $2.76 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 10.15 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Featured Story: Treasury Bonds
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.